FDA Regulation of Underage ENDS Use and the Incidence of Fatal Lung Disease.
The Food and Drug Administration (FDA) has tightened its regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS) since it promulgated a rule extending existing tobacco regulations to ENDS in August of 2016. Many of these regulatory developments occurred under former FDA Commissioner Scott Gottlieb with the objective of […]
Google, Fitbit, and the Sale of Our Private Health Data
On November 1, 2019, Google’s Senior Vice President of Devices and Services Rick Osterloh announced in a blog post that Google had entered into an agreement to acquire Fitbit, Inc. This move signaled Google’s efforts to become a leading company in the $25 billion wearables market after failing to make […]
We the Pat[i]ents: HHS v Gilead
On November 6, 2019, the US Department of Health and Human Services (HHS) filed suit against pharmaceutical manufacturer Gilead Sciences, Inc., seeking damages against the company for infringing on HHS patents for pre-exposure prophylaxis (known as “PrEP”) for HIV prevention. Gilead manufactures and sells two pills—Descovy and Truvada—for use in […]
States Take Regulatory Measures to Protect Youth from E-Cigarettes
Over the past decade, electric cigarettes or commonly referred to as e-cigarettes have become a blossoming market as technology has upgraded traditional cigarettes. The e-cigarette industry has urged that vaping is a “safer” method of smoking. In August 2019, e-cigarettes claimed its first victim. Earlier this year, the Center for […]
Medicaid’s Power to Recoup: Estate Recovery and Long-Term Care
Financing long-term services and supports (LTSS) presents a concern to older adults, lawmakers, and society at large. LTSS refers to those services that meet a person’s routine health and personal care needs when he no longer can perform these tasks on his own, often due to age or disability. Affording […]
